Lucid Diagnostics Inc.
LUCD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,211 | $1 | $1 | $1 |
| % Growth | 104,027.3% | 40.5% | -30.8% | – |
| Cost of Goods Sold | $1,697 | $2 | $2 | $2 |
| Gross Profit | -$486 | -$1 | -$1 | -$1 |
| % Margin | -40.1% | -53.5% | -87.3% | -79.2% |
| R&D Expenses | $1,272 | $1 | $1 | $1 |
| G&A Expenses | $5,605 | $5,617 | $6 | $6 |
| SG&A Expenses | $9,896 | $9,624 | $10 | $10 |
| Sales & Mktg Exp. | $4,291 | $4,007 | $4 | $4 |
| Other Operating Expenses | $105 | -$9,614 | $0 | $0 |
| Operating Expenses | $11,273 | $11 | $12 | $11 |
| Operating Income | -$11,759 | -$11 | -$12 | -$12 |
| % Margin | -971% | -978.8% | -1,508.1% | -1,033.8% |
| Other Income/Exp. Net | $1,362 | $7 | -$14 | $1 |
| Pre-Tax Income | -$10,397 | -$4 | -$27 | -$12 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,397 | -$4 | -$27 | -$12 |
| % Margin | -858.5% | -381.7% | -3,249.8% | -964.2% |
| EPS | -0.1 | -0.08 | -0.52 | -0.2 |
| % Growth | -25.5% | 84.7% | -160% | – |
| EPS Diluted | -0.1 | -0.08 | -0.52 | -0.2 |
| Weighted Avg Shares Out | 108 | 99 | 69 | 58 |
| Weighted Avg Shares Out Dil | 108 | 99 | 69 | 58 |
| Supplemental Information | – | – | – | – |
| Interest Income | $101 | $0 | $0 | $0 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $441 | $0 | $0 | $0 |
| EBITDA | -$9,954 | -$4 | -$27 | -$11 |
| % Margin | -822% | -362.1% | -3,222% | -945% |